Grifols, S.A. revenue for the last year amounted to 7.13 B USD, the most of which — 6.01 B USD — came from its highest performing source at the moment, Biopharma, the year earlier bringing 5.26 B USD. The greatest contribution to the revenue figure was made by United States and Canada — last year it brought Grifols, S.A. 4.22 B USD, and the year before that — 4.05 B USD.